Please login to the form below

Not currently logged in

Excellence in Innovation

Sponsored by

Back to Results

Highly Commended


by Boehringer Ingelheim International GmbH
with support from infill healthcare communication

Summary of work

opnMe is an innovation initiative by Boehringer Ingelheim that aims to strengthen the company’s visibility as collaboration partner of choice for scientific research and early-stage drug discovery projects. By granting free access to its compounds and research tools, the company hopes to increase its scientific network and to accelerate the science in areas of high medical unmet need, giving patients access to medicines sooner.

The initiative targets the international scientific community such as academic, biotech and research organisations. Providing non-bureaucratic access to research compounds via an online platform, the company aims to attract innovative target proposals that have been generated externally thereby fostering an earlier start to translational medicine.

The benefits for participating scientists reach from increased scientific reputation (resulting from independent publications), access to the scientific expertise of a pharmaceutical company for networking and collaborative idea generation, to potentially a prospect for IP which could be licensed back to the company. is the centrepiece of the initiative as it serves as a contact tool, an information resource, a distribution tool and conduit to research tools.

Since Jan 2019,

  • 78,694 unique visitors have accessed the site
  • Scientists from 40 countries ordered molecules
  • A total of 645 orders were received and shipped
  • 17 collaborations have been formalised.

Judges' comments

opnMe showed a clear commitment to fostering an open-minded and collaborative relationship with the global scientific community. It offered a ‘no strings attached’ approach to molecule research and to experts who can engage and discuss different areas of research.

Highly commended

opnMe - by Boehringer Ingelheim International GmbH
with support from infill healthcare communication

Highly commended

The What If? Accelerator - by Roche
with support from Virgo Health


Online Diagnostic Ambulance - by London Ambulance Service and Abbott plc

myPKFiT™ Mobile App - by Takeda UK

Key dates

Entry deadline 26 August 2022
Extended entry deadline 2 September 2022*
*additional fee applies
Judging Day 6 October 2022
Company/Team of the Year Interviews 21 October 2022
PMEA Event 23 November 2022